Cardiovascular Catch-Up: Abbott, Medtronic, Boston Scientific Stay Hot During Summer

June, July and August brought a number of important new approvals and trial announcements from the major cardiac device companies. Here are some of the highlights you might have missed during the summer.

Heart
• Source: Shutterstock

Medtronic announced the start of DEFINE AFib, the company’s first “app-based” research study in June.

The 5,000-patient cohort study, led by researchers at Duke University in North Carolina, will collect data on patient outcomes, quality of life, and health care utilization using Medtronic’s Linq

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D